Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Daiichi Sankyo
Baxter
Deloitte
McKesson
Cipla
US Department of Justice
Moodys
Covington
Chinese Patent Office

Generated: February 23, 2018

DrugPatentWatch Database Preview

KANAMYCIN SULFATE Drug Profile

« Back to Dashboard

When do Kanamycin Sulfate patents expire, and what generic alternatives are available?

Kanamycin Sulfate is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, Intl Medication, Loch, Pharmafair, Solopak, Warner Chilcott, and Watson Labs. and is included in twelve NDAs.

The generic ingredient in KANAMYCIN SULFATE is kanamycin sulfate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the kanamycin sulfate profile page.
Drug patent expirations by year for KANAMYCIN SULFATE
Medical Subject Heading (MeSH) Categories for KANAMYCIN SULFATE

US Patents and Regulatory Information for KANAMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062504-003 Apr 5, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062520-003 May 9, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Intl Medication KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062466-001 Sep 30, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 065111-002 Dec 17, 2002 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmafair KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062668-001 May 7, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Loch KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 063025-001 Jul 31, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Solopak KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062605-001 Feb 26, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Solopak KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062605-002 Feb 26, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abraxis Pharm KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062504-001 Apr 5, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abraxis Pharm KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062504-002 Apr 5, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Cantor Fitzgerald
Citi
Daiichi Sankyo
Chinese Patent Office
Medtronic
McKesson
Federal Trade Commission
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot